Benjamin Rolles

12PUBLICATIONS
79CO-AUTHORS
Regenerative medicine (incl. stem cells)Gene and molecular therapyMolecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Feb 26, 2026
Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicing.

Jonas S Jutzi, Edie Crosse, Chulwoo J Kim

|Feb 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.

Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson

|Sep 18, 2025
Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis.

Abdulrahman Alhajahjeh, Naira Link Woite, Benjamin Rolles

|Jun 30, 2025
ZIP10 as a potential therapeutic target in acute myeloid leukaemia.

Benjamin Rolles, Nicolas Chatain, Richard Görg

Pageof 2

Frequent Collaborators

3 joint publications

Jan Philipp Bewersdorf

3 joint publications

Anna E Marneth

2 joint publications

Tim H Brümmendorf

2 joint publications

Joan How